Key findings

A dose-dependent relationship exists between doxorubicin-based chemotherapy for childhood cancer and subsequent development of breast cancer, according to a new analysis that pools individual patient data from six well-established cohort studies. A cumulative threshold dose of 200 mg/m ² is associated with doubling of breast cancer risk (vs ...